Prognosis Value of RBBP8 Expression in Plasma Cell Myeloma

Cancer Gene Therapy - United Kingdom
doi 10.1038/s41417-018-0069-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Expression of CD81 and CD117 in Plasma Cell Myeloma and the Relationship to Prognosis

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Plasma Cell Satellitism in Plasma Cell Myeloma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Increased Circulating Plasma Cells Detected by Flow Cytometry Predicts Poor Prognosis in Patients With Plasma Cell Myeloma

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2017English

Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Prognostic Value of CD56 Expression in Multiple Myeloma

Research in Oncology
2020English

Enhanced Expression of FCER1G Predicts Positive Prognosis in Multiple Myeloma

Journal of Cancer
Oncology
2020English

Myeloma Therapy: Pursuing the Plasma Cell

British Journal of Cancer
Cancer ResearchOncology
2010English

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

IgE Myeloma Associated With Plasma Cell Leukaemia.

Postgraduate Medical Journal
Medicine
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy